Privia Health Group Files 8-K on Shareholder Votes and Bylaws

Ticker: PRVA · Form: 8-K · Filed: 2024-05-23T00:00:00.000Z

Sentiment: neutral

Topics: corporate-governance, filing, bylaws

Related Tickers: PRVA

TL;DR

PRVA filed an 8-K detailing shareholder votes and bylaw changes; check for governance updates.

AI Summary

Privia Health Group, Inc. filed an 8-K on May 22, 2024, reporting on matters submitted to a vote of security holders and financial statements. The filing also includes amendments to its articles of incorporation or bylaws and a change in its fiscal year. The company is incorporated in Delaware and its principal executive offices are located in Arlington, Virginia.

Why It Matters

This filing provides updates on corporate governance and financial reporting, which are crucial for investors to understand the company's operational and structural changes.

Risk Assessment

Risk Level: low — This is a routine corporate filing detailing procedural matters and financial statements, not indicating immediate operational or financial distress.

Key Players & Entities

FAQ

What specific matters were submitted to a vote of security holders?

The filing indicates that matters were submitted to a vote of security holders, but the specific details of these matters are not elaborated upon in the provided text.

What are the key changes in the company's articles of incorporation or bylaws?

The filing states there were amendments to the articles of incorporation or bylaws, but the specific amendments are not detailed in the provided excerpt.

Has Privia Health Group, Inc. changed its fiscal year end?

Yes, the filing indicates a change in the fiscal year, though the new end date is not specified in this excerpt.

When was Privia Health Group, Inc. incorporated?

The company is incorporated in Delaware, as stated in the filing.

What is the primary business address of Privia Health Group, Inc.?

The principal executive offices are located at 950 N. Glebe Rd., Suite 700, Arlington, Virginia 22203.

From the Filing

0001759655-24-000076.txt : 20240523 0001759655-24-000076.hdr.sgml : 20240523 20240523162028 ACCESSION NUMBER: 0001759655-24-000076 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240522 ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240523 DATE AS OF CHANGE: 20240523 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Privia Health Group, Inc. CENTRAL INDEX KEY: 0001759655 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40365 FILM NUMBER: 24978563 BUSINESS ADDRESS: STREET 1: 950 N. GLEBE RD., SUITE 700 CITY: ARLINGTON STATE: VA ZIP: 22203 BUSINESS PHONE: 571-366-8850 MAIL ADDRESS: STREET 1: 950 N. GLEBE RD., SUITE 700 CITY: ARLINGTON STATE: VA ZIP: 22203 FORMER COMPANY: FORMER CONFORMED NAME: PH Group Parent Corp. DATE OF NAME CHANGE: 20181120 8-K 1 prva-20240522.htm 8-K prva-20240522 0001759655 FALSE 12/31 0001759655 2024-05-22 2024-05-22 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ FORM 8-K _______________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 22, 2024 _________________________ Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) _________________________ Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organization) (Commission File No.) (I.R.S. Employer Identification No.) 950 N. Glebe Rd., Suite 700 Arlington, Virginia 22203 (Address of Principal Executive Offices) (Zip Code) ( 571 ) 366-8850 Registrant's telephone number, including area code Not Applicable (Former name, former address and former fiscal year, if changed since last report) Check the appropriate box below if the form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2 (b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value per share PRVA The Nasdaq Global Select Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On May 22, 2024, Privia Health Group, Inc. (the “Company”) held its 2024 Annual Meeting of Stockholders (the "Annual Meeting"). At the Annual Meeting, the Company’s stockholders approved amendments to the Company’s Amended and Restated Certificate of Incorporation (the “Charter”) to remove supermajority voting provisions and to remove or limit the personal liability of officers to the extent

View on Read The Filing